CNN Central News & Network–ITDC India Epress/ITDC News Bhopal: In India’s complex and expensive healthcare ecosystem, where sufferers still consume a significant portion of their income on pharmaceuticals, a quiet transformation is ongoing. While digital health startups often lead headlines, one drugstore chain is leading a hidden but impactful transformation. Medkart, based in Gujarat and focused solely on generic medicines, is helping Indian households save up to INR 300 crore every year by rethinking how access to affordable medicine should work.
The Everyday Cost Burden of Medicines
India’s healthcare system places a heavy financial load on patients. According to National Health Accounts data, households paid nearly 40% of total health expenditures out-of-pocket in 2021–22, a slight improvement from previous years, but still among the highest globally. Medicines account for the largest portion of this burden. Research shows that over half of household health spending in India goes to purchasing medicines.
This situation disproportionately affects people managing chronic diseases like diabetes, cardiovascular conditions, and cancer. Even when generics are available, scepticism.
around their quality leads many patients to stick with expensive branded options, increasing their monthly financial stress.
Why Many Still Choose Branded Drugs
A 2023 study on medicine perception in India revealed that a majority of patients prefer branded drugs over generics. The main reasons? Concerns about quality, trust, and lack of transparent product information. According to PwC and Deloitte, closing the awareness gap and improving trust in generics is crucial for lowering healthcare costs across emerging markets.
Despite being bioequivalent, generics often suffer from a credibility deficit. Without clear labelling, pricing transparency, or pharmacist validation, most patients hesitate to make the switch.
How Medkart Makes Generics Work for Everyone
Founded in 2014, Medkart chose to solve this trust problem head-on. Its business model is centred on high-quality generics, verified sources, and a tech-first platform to help patients make informed choices. The company doesn’t list branded options—it offers verified generic alternatives and tells you how much you’re saving.
Its app and website include a price comparison engine that shows users how much they could save by switching to generics. These tools break down composition, strength, and pricing side-by-side. Most users report savings between 50% and 85% depending on the medicine.
For example, the antifungal medicine Voriconazole (Vorier), often used in cancer recovery, typically sells for nearly INR 5,000 or more. Medkart provides an equally effective alternative for just INR 720—a saving of 86%.
What Sets Medkart Apart
Medkart’s biggest value is its backend quality assurance. Every product sold is “Medkart Assured”—meaning it is sourced only from manufacturers compliant with Schedule-M, India’s GMP standard. The company performs audits and checks to ensure the quality before it reaches the shelves or customer homes.
#PharmacyChain #AffordableHealthcare #HealthcareSavings #GenericMedicines #IndiaHealthcare #300CroreSavings #PharmaInnovation
